247 related articles for article (PubMed ID: 21694819)
1. Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Yoon MS; Chan A; Gold R
Ther Adv Neurol Disord; 2011 May; 4(3):193-200. PubMed ID: 21694819
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic inflammatory demyelinating polyneuropathy.
Robertson EE; Donofrio PD
Curr Treat Options Neurol; 2010 Mar; 12(2):84-94. PubMed ID: 20842572
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
4. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
5. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
6. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
[TBL] [Abstract][Full Text] [Related]
8. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
9. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
Iijima M
Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
De Sousa EA; Brannagan TH
Curr Treat Options Neurol; 2006 Mar; 8(2):91-103. PubMed ID: 16464406
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
[TBL] [Abstract][Full Text] [Related]
14. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
Iijima M; Koike H; Sobue G
Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
[TBL] [Abstract][Full Text] [Related]
16. Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA; Bengrine T; van Rijs W; Baas F; Nagelkerke SQ; Kuijpers TW; Fokkink WR; Bunschoten C; Broers MC; Willemsen SP; Jacobs BC; Huizinga R
Eur J Neurol; 2021 May; 28(5):1677-1683. PubMed ID: 33460483
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
[TBL] [Abstract][Full Text] [Related]
18. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.
Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG
BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.
Marsh EA; Hirst CL; Llewelyn JG; Cossburn MD; Reilly MM; Krishnan A; Doran M; Ryan AM; Coles AJ; Jones JL; Robertson NP
J Neurol; 2010 Jun; 257(6):913-9. PubMed ID: 20049473
[TBL] [Abstract][Full Text] [Related]
20. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA
Drugs; 2009 May; 69(8):987-1001. PubMed ID: 19496628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
